JPS5770814A - Oral preparation of blood clotting eighth factor - Google Patents
Oral preparation of blood clotting eighth factorInfo
- Publication number
- JPS5770814A JPS5770814A JP55144508A JP14450880A JPS5770814A JP S5770814 A JPS5770814 A JP S5770814A JP 55144508 A JP55144508 A JP 55144508A JP 14450880 A JP14450880 A JP 14450880A JP S5770814 A JPS5770814 A JP S5770814A
- Authority
- JP
- Japan
- Prior art keywords
- factor
- ribosome
- blood clotting
- oral preparation
- enclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000023555 blood coagulation Effects 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 abstract 2
- 108010039627 Aprotinin Proteins 0.000 abstract 1
- 208000031220 Hemophilia Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 229940122618 Trypsin inhibitor Drugs 0.000 abstract 1
- 101710162629 Trypsin inhibitor Proteins 0.000 abstract 1
- 229960004405 aprotinin Drugs 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 239000002753 trypsin inhibitor Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55144508A JPS5770814A (en) | 1980-10-17 | 1980-10-17 | Oral preparation of blood clotting eighth factor |
| GB8130122A GB2085729B (en) | 1980-10-17 | 1981-10-06 | Pharmaceutical composition for oral administration containing coagulation factor viii |
| US06/309,269 US4348384A (en) | 1980-10-17 | 1981-10-07 | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
| DE19813141223 DE3141223A1 (de) | 1980-10-17 | 1981-10-16 | "oral verabreichbare arzneimittel zur therapie und prophylaxe von haemophilie a" |
| FR8119522A FR2492260A1 (fr) | 1980-10-17 | 1981-10-16 | Composition pharmaceutique pour l'administration orale contenant le facteur de coagulation viii |
| ES506320A ES506320A0 (es) | 1980-10-17 | 1981-10-16 | Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55144508A JPS5770814A (en) | 1980-10-17 | 1980-10-17 | Oral preparation of blood clotting eighth factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5770814A true JPS5770814A (en) | 1982-05-01 |
| JPH03366B2 JPH03366B2 (enrdf_load_html_response) | 1991-01-07 |
Family
ID=15363986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55144508A Granted JPS5770814A (en) | 1980-10-17 | 1980-10-17 | Oral preparation of blood clotting eighth factor |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5770814A (enrdf_load_html_response) |
| DE (1) | DE3141223A1 (enrdf_load_html_response) |
| ES (1) | ES506320A0 (enrdf_load_html_response) |
| FR (1) | FR2492260A1 (enrdf_load_html_response) |
| GB (1) | GB2085729B (enrdf_load_html_response) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056918A (ja) * | 1983-08-03 | 1985-04-02 | ビオメデイカ・フオスカマ・インデユストリア・キミコ−フアルマチエウテイカ・エツセ・ピ・ア | フルクト−ス−１，６−２燐酸含有リポソ−ム |
| JPS6069027A (ja) * | 1983-06-27 | 1985-04-19 | クイ−ンズ ユニバ−シテイ アツト キングストン | 止血用薬剤組成物 |
| JPS6150912A (ja) * | 1984-08-16 | 1986-03-13 | Shionogi & Co Ltd | リポソ−ム製剤の製造法 |
| JP2001514209A (ja) * | 1997-09-04 | 2001-09-11 | バイオゾーン ラボラトリーズ，インコーポレイテッド | 経口リポソーム送達系 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2581543B1 (fr) * | 1985-05-09 | 1989-07-07 | Tressens Dominique | Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale |
| DE3625090A1 (de) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung |
| GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
| DE4115453A1 (de) * | 1991-05-11 | 1992-11-12 | Knoll Ag | Neue wirkstoffkombination |
| WO1994028876A1 (en) * | 1993-06-07 | 1994-12-22 | Advanced Therapies, Inc. | Liposome powders |
| FR2706302B1 (fr) * | 1993-06-18 | 1995-08-18 | Franche Comte Universite | Produit alcalinisant sous forme gastro-résistante. |
| US6017891A (en) * | 1994-05-06 | 2000-01-25 | Baxter Aktiengesellschaft | Stable preparation for the treatment of blood coagulation disorders |
| DE4416180C2 (de) * | 1994-05-06 | 1997-08-14 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats |
| DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
| CH689139A5 (de) * | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung. |
| EP2130554B1 (en) | 1999-02-22 | 2012-09-05 | University of Connecticut | Albumin-free factor VIII formulations |
| KR101752508B1 (ko) | 2008-11-07 | 2017-06-29 | 백스터 인터내셔널 인코포레이티드 | 제8 인자 제형 |
| DE102009001334B4 (de) | 2009-03-04 | 2017-02-23 | Stefan Brosig | Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen |
| CN109316599A (zh) * | 2018-08-24 | 2019-02-12 | 上海交通大学医学院附属瑞金医院 | 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
| NL7900459A (nl) * | 1979-01-19 | 1980-07-22 | Hendrik Coenraad Hemker Prof D | Farmaceutisch preparaat en werkwijze ter bereiding daarvan. |
-
1980
- 1980-10-17 JP JP55144508A patent/JPS5770814A/ja active Granted
-
1981
- 1981-10-06 GB GB8130122A patent/GB2085729B/en not_active Expired
- 1981-10-16 ES ES506320A patent/ES506320A0/es active Granted
- 1981-10-16 FR FR8119522A patent/FR2492260A1/fr active Granted
- 1981-10-16 DE DE19813141223 patent/DE3141223A1/de not_active Withdrawn
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6069027A (ja) * | 1983-06-27 | 1985-04-19 | クイ−ンズ ユニバ−シテイ アツト キングストン | 止血用薬剤組成物 |
| JPS6056918A (ja) * | 1983-08-03 | 1985-04-02 | ビオメデイカ・フオスカマ・インデユストリア・キミコ−フアルマチエウテイカ・エツセ・ピ・ア | フルクト−ス−１，６−２燐酸含有リポソ−ム |
| JPS6150912A (ja) * | 1984-08-16 | 1986-03-13 | Shionogi & Co Ltd | リポソ−ム製剤の製造法 |
| JP2001514209A (ja) * | 1997-09-04 | 2001-09-11 | バイオゾーン ラボラトリーズ，インコーポレイテッド | 経口リポソーム送達系 |
| JP2010001317A (ja) * | 1997-09-04 | 2010-01-07 | Biozone Lab Inc | 経口リポソーム送達系 |
Also Published As
| Publication number | Publication date |
|---|---|
| ES8306323A1 (es) | 1983-05-16 |
| ES506320A0 (es) | 1983-05-16 |
| FR2492260A1 (fr) | 1982-04-23 |
| GB2085729B (en) | 1984-04-18 |
| DE3141223A1 (de) | 1982-06-24 |
| FR2492260B1 (enrdf_load_html_response) | 1984-07-27 |
| JPH03366B2 (enrdf_load_html_response) | 1991-01-07 |
| GB2085729A (en) | 1982-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5770814A (en) | Oral preparation of blood clotting eighth factor | |
| IL71506A (en) | Rapid dissolving,uniform pharmaceutical compositions of low water solubility drugs and their preparation | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| HUT54885A (en) | Process for producing liofilized pharmaceutical compositions containing active components | |
| IL60474A (en) | Cyclopeptides of the somatostatin type,their manufacture and pharmaceutical compositions containing them | |
| JPS5231839A (en) | Drug for cosmetics and permanent wave in combination | |
| ZA848141B (en) | New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions | |
| JPS5442380A (en) | Regenerative capsule | |
| JPS536430A (en) | Preparation of anticoagulant soft material for medical use | |
| DK468388A (da) | Kompleks af polyethylenglycol og vaevplasminogen-aktivator, fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende komplekset | |
| JPS649932A (en) | Soft capsule preparation using newly combined component as the base | |
| DE3166925D1 (en) | Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes | |
| JPS5238483A (en) | Process for making a unificated fabric mainly composed of a reticular substance | |
| JPS53139716A (en) | Pharmaceutical preparation of stable prostaglandine | |
| JPS5231125A (en) | Metal fibers and their preparation | |
| JPS57179122A (en) | Blood coagulation factor ix preparation for oral administration | |
| JPS5590503A (en) | Chitin molding material | |
| JPS577422A (en) | Crocosmia aurea "plach" | |
| JPS5341418A (en) | Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration | |
| JPS521203A (en) | Manufacturing method of rotor material of rotor unit | |
| JPS51130519A (en) | Process for preparating collagen powder for hemostasis | |
| JPS52130905A (en) | Medicinal composition | |
| JPS5338617A (en) | Preparation of hepatitis-b vaccine | |
| EP0055499A3 (en) | Non-bleeding chewable tablets having high lipid content | |
| JPS5665823A (en) | N-ethylcarbaminomethylisoleucine pharmaceutical for oral administration |